	US 12,011,443 B2
	Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis
Jae-Sun Kim, Suwon-si (KR); Hyung-Chul Ryu, Osan-Si (KR); Jee-Woong Lim, Seongnam-Si (KR); Jung-Gun Joung, Hwaseong-Si (KR); Sun-Joo Kim, Suwon-Si (KR); Yeon-Woo Son, Hwaseong-Si (KR); Hyung-Jun Kim, Asan-Si (KR); and Wenling Song, Uiwang-Si (KR)
Assigned to J2H BIOTECH INC., Suwon-si (KR)
Appl. No. 17/262,084
Filed by J2H BIOTECH INC., Suwon-Si (KR)
PCT Filed Jul. 19, 2019, PCT No. PCT/KR2019/008963 § 371(c)(1), (2) Date Jan. 21, 2021, PCT Pub. No. WO2020/022708, PCT Pub. Date Jan. 30, 2020.
Claims priority of application No. 10-2018-0085431 (KR), filed on Jul. 23, 2018.
Prior Publication US 2021/0299127 A1, Sep. 30, 2021
Int. Cl. A61K 31/506 (2006.01); A61P 1/16 (2006.01)

CPC A61K 31/506 (2013.01) [A61P 1/16 (2018.01)]

3 Claims

1. A method for treating or preventing non-alcoholic steatohepatitis, the method comprising administering to a subject in need thereof a therapeutically or prophylactically effective amount of a pharmaceutical composition comprising a pyrimidine-4-carboxamide compound of Chemical Formula 1 as an active ingredient, wherein Chemical Formula 1 is